WHO moves to update COVID-19 guidance after 'great news' in drug study

United States News News

WHO moves to update COVID-19 guidance after 'great news' in drug study
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

The World Health Organization (WHO) said it was moving to update its guidelines on treating people stricken with COVID-19 to reflect results of a clinical trial that showed a cheap, common steroid can help save critically ill patients.

Trial results announced on Tuesday showed dexamethasone, used since the 1960s to reduce inflammation in diseases such as arthritis, cut death rates by around a third among the most severely ill COVID-19 patients admitted to hospital.

Although the dexamethasone study’s results are preliminary, the researchers behind the project said it suggests the drug should immediately become standard care in severely stricken patients. The benefit was only seen in patients seriously ill with COVID-19 and was not observed in patients with milder disease.

“This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement late on Tuesday. The agency said it was looking forward to the full data analysis of the study in coming days.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca COVID-19 vaccine likely to protect for a year - CEOAstraZeneca COVID-19 vaccine likely to protect for a year - CEOAstraZeneca's potential coronavirus vaccine is likely to provide protection against contracting COVID-19 for about a year, the company's chief executive told a Belgian radio station on Tuesday.
Read more »

Ukraine president's wife hospitalized with moderate COVID-19Ukraine president's wife hospitalized with moderate COVID-19The wife of Ukraine's President, Olena Zelenska, was hospitalized after contracting coronavirus and her condition was stable, the presidential office said on Tuesday, adding a fresh test of her husband showed he remained negative.
Read more »

Pence Says Oklahoma COVID-19 Cases Have 'Flattened' — 2 Days After Record JumpPence Says Oklahoma COVID-19 Cases Have 'Flattened' — 2 Days After Record JumpTulsa's health department head said the city, site of Trump's rally Saturday, is seeing 'a significant increase in our case trends.'
Read more »

What You Should Keep In Mind About COVID-19 If You're Protesting, According To A DoctorWhat You Should Keep In Mind About COVID-19 If You're Protesting, According To A DoctorThe short answer: Wear a mask and sanitize, sanitize, sanitize. But of course there's more to it than that.
Read more »

COVID-19 Tracking Apps ‘A Privacy Trash Fire’ As Norway Nixes Its OwnCOVID-19 Tracking Apps ‘A Privacy Trash Fire’ As Norway Nixes Its OwnI'm associate editor for Forbes, covering security, surveillance and privacy. I’ve been breaking news and writing features on these topics for major publications since 2010. As a freelancer, I worked for The Guardian, Vice Motherboard, Wired and BBC.com, amongst many others. I was named BT Security Journalist of the year in 2012 and 2013 for a range of exclusive articles, and in 2014 was handed Best News Story for a feature on US government harassment of security professionals. I like to hear from hackers who are breaking things for either fun or profit and researchers who've uncovered nasty things on the web. Tip me on Signal at 447837496820. I use WhatsApp and Treema too. Or you can email me at TBrewsterforbes.com, or tbthomasbrewstergmail.com.
Read more »

Imperial College set to launch human trials of potential Covid-19 vaccineImperial College set to launch human trials of potential Covid-19 vaccineThe trials, partially funded by the UK, are the first human tests of a technology that researchers say could transform vaccine development by enabling rapid responses to emerging diseases such as the infection caused by the SARS-CoV-2.
Read more »



Render Time: 2025-03-02 23:52:02